Analyst Ratings for Aardvark Therapeutics Inc (AARD)
AARD Rating Summary
AARD Price Target Summary
- Highest: $28.00 (Raymond James)
- Lowest: $3.00 (Morgan Stanley)
- Average: $13.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.88 (+264.2%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 61%
Avg. $ Target:
$13.88 (+264.2%)
* Over Last 12-Mos
Rating Score: 5.8 / 10
Percentile Rank: 61%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | BTIG | Jeet Mukherjee | Downgrade | Neutral (Buy) |
N/A (N/A) |
6.73 (3.81) |
-43.39% | Details |
| 5/15/2026 | Morgan Stanley | Michael E Ulz | Downgrade | Underweight (Equalweight) |
3.00 (7.00) |
6.59 (3.81) |
-42.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
